Abbvie Inc. (ABBV) — 10-Q Filings
All 10-Q filings from Abbvie Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
AbbVie's Q3 Earnings Plummet 88% Amidst Aggressive R&D Investments
— Nov 4, 2025 Risk: medium
AbbVie Inc. reported a significant decline in net earnings for the three months ended September 30, 2025, falling to $186 million from $1,561 million in the pri -
AbbVie Q2 Earnings Dip Amid Revenue Decline, Legal Headwinds
— Aug 4, 2025 Risk: high
AbbVie Inc. reported total net revenues of $13.725 billion for the second quarter ended June 30, 2025, a decrease from $13.869 billion in the prior-year quarter - 10-Q Filing — May 9, 2025
-
AbbVie Inc. Files Q3 2024 10-Q Financial Report
— Nov 4, 2024 Risk: low
AbbVie Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position, including revenue, exp -
AbbVie Inc. Files Q2 2024 10-Q Report
— Aug 7, 2024 Risk: low
AbbVie Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company's fiscal year ends on December 31, 2024. Key - 10-Q Filing — May 3, 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX